• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒肺炎患者白细胞DNA损伤的临床研究

Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients.

作者信息

Doğan Hasan, Kara Aslı, Çankaya Erdem, Balkan Eda, Gürbüz Muhammet Ali, Kızılkaya Murat, Aykaç Merve

机构信息

Department of Medical Biology, Faculty of Medicine, Ataturk University, Erzurum 25240, Turkey.

Department of Internal Medicine, Erzurum Regional Training and Research Hospital, Health Sciences University, Erzurum 25100, Turkey.

出版信息

Curr Issues Mol Biol. 2023 Jan 19;45(2):963-974. doi: 10.3390/cimb45020062.

DOI:10.3390/cimb45020062
PMID:36826007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9955698/
Abstract

This prospective cross-sectional study aimed to evaluate leukocyte DNA damage in coronavirus disease (COVID-19) patients. In this study, 50 COVID-19-positive patients attending the Erzurum City Hospital Internal Medicine Outpatient Clinic and 42 control group patients were included. DNA damage was detected in living cells through leukocyte isolation in 50 COVID-19-positive patients using the comet assay method. DNA tail/head (olive) moments were evaluated and compared. White blood cells (WBC), red blood cells (RBC), hemoglobin (HGB), neutrophils (NEU), lymphocytes (LYM), eosinophils (EO), monocytes (MONO), basophils (BASO), platelets (PLT), and the neutrophil/lymphocyte ratio (NLR) were analyzed. The RBC, lymphocyte, eosinophil, and monocyte means were significantly higher in the control group ( < 0.05), whereas the HGB and neutrophile means were significantly higher in the study group ( < 0.05). There were significant negative correlations between COVID-19 and RBC (r = -0.863), LYM (r = -0.542), EO (r = -0.686), and MONO (r = -0.385). Meanwhile, there were significant positive correlations between COVID-19 and HGB (r = 0.863), NEU (r = 0.307), tail moment (r = 0.598), and olive moment (r = 0.582). Both the tail and olive moment mean differences were significantly higher in the study group, with higher ranges ( < 0.05). COVID-19 infection caused statistically significant increases in both the tail and olive damage percentage in patients, causing DNA damage. Lastly, the NLR rate was associated with the presence and progression of COVID-19.

摘要

这项前瞻性横断面研究旨在评估冠状病毒病(COVID-19)患者的白细胞DNA损伤。在本研究中,纳入了50名就诊于埃尔祖鲁姆市医院内科门诊的COVID-19阳性患者和42名对照组患者。采用彗星试验法,通过对50名COVID-19阳性患者进行白细胞分离,检测活细胞中的DNA损伤。对DNA尾/头(橄榄)矩进行评估和比较。分析了白细胞(WBC)、红细胞(RBC)、血红蛋白(HGB)、中性粒细胞(NEU)、淋巴细胞(LYM)、嗜酸性粒细胞(EO)、单核细胞(MONO)、嗜碱性粒细胞(BASO)、血小板(PLT)以及中性粒细胞/淋巴细胞比值(NLR)。对照组的红细胞、淋巴细胞、嗜酸性粒细胞和单核细胞平均值显著更高(<0.05),而研究组的血红蛋白和中性粒细胞平均值显著更高(<0.05)。COVID-19与红细胞(r = -0.863)、淋巴细胞(r = -0.542)、嗜酸性粒细胞(r = -0.686)和单核细胞(r = -0.385)之间存在显著负相关。同时,COVID-19与血红蛋白(r = 0.863)、中性粒细胞(r = 0.307)、尾矩(r = 0.598)和橄榄矩(r = 0.582)之间存在显著正相关。研究组的尾矩和橄榄矩平均差异均显著更高,范围更大(<0.05)。COVID-19感染导致患者的尾损伤百分比和橄榄损伤百分比均有统计学意义的增加,造成DNA损伤。最后,NLR率与COVID-19的存在和进展相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc8/9955698/ca5d591bd634/cimb-45-00062-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc8/9955698/815abc9ccc3c/cimb-45-00062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc8/9955698/83f44cc95a92/cimb-45-00062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc8/9955698/ca5d591bd634/cimb-45-00062-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc8/9955698/815abc9ccc3c/cimb-45-00062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc8/9955698/83f44cc95a92/cimb-45-00062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc8/9955698/ca5d591bd634/cimb-45-00062-g003a.jpg

相似文献

1
Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients.新冠病毒肺炎患者白细胞DNA损伤的临床研究
Curr Issues Mol Biol. 2023 Jan 19;45(2):963-974. doi: 10.3390/cimb45020062.
2
[Dynamic monitoring of the neutrophil/lymphocyte ratio could predict the prognosis of patients with bloodstream infection].中性粒细胞/淋巴细胞比值动态监测可预测血流感染患者的预后
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jun;27(6):471-6. doi: 10.3760/cma.j.issn.2095-4352.2015.06.011.
3
Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19.全身免疫炎症指数和中性粒细胞与淋巴细胞比值对重症 COVID-19 患者的预测价值。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221111391. doi: 10.1177/10760296221111391.
4
[Correlation between neutrophil/lymphocyte ratio combined with low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with acute coronary syndrome].[中性粒细胞/淋巴细胞比值联合低密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值与急性冠状动脉综合征患者冠状动脉疾病严重程度的相关性]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Mar;34(3):274-279. doi: 10.3760/cma.j.cn121430-20211008-01441.
5
[Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].[中性粒细胞与淋巴细胞比值在新型冠状病毒肺炎分型诊断中的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):554-558. doi: 10.3760/cma.j.cn121430-20200413-00506.
6
Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters.利用血液学参数组合鉴别新冠肺炎重症与中症病例的初步研究
Ann Transl Med. 2020 May;8(9):593. doi: 10.21037/atm-20-3391.
7
Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19.中性粒细胞与淋巴细胞比值、淋巴细胞与单核细胞比值及血小板与淋巴细胞比值预测 COVID-19 严重程度。
Am J Emerg Med. 2021 Feb;40:110-114. doi: 10.1016/j.ajem.2020.11.058. Epub 2020 Dec 6.
8
Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.外周血标志物对 2019 年冠状病毒病(COVID-19)的诊断价值:一项多中心、横断面研究。
J Clin Lab Anal. 2020 Oct;34(10):e23475. doi: 10.1002/jcla.23475. Epub 2020 Jul 17.
9
[Expressions of MPV, P-LCR and NLR in patients with novel coronavirus disease 2019].[2019年新型冠状病毒病患者中MPV、P-LCR和NLR的表达]
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Jul 6;55(7):890-895. doi: 10.3760/cma.j.cn112150-20200705-00973.
10
Evaluation of complete blood cell count parameters and lymphocyte-related ratios in patients with Opioid Use Disorder.评估阿片类药物使用障碍患者的全血细胞计数参数和淋巴细胞相关比值。
J Immunoassay Immunochem. 2022 May 4;43(3):259-270. doi: 10.1080/15321819.2021.2001001. Epub 2021 Nov 29.

引用本文的文献

1
DNA Damage in Moderate and Severe COVID-19 Cases: Relation to Demographic, Clinical, and Laboratory Parameters.中度和重度 COVID-19 病例中的 DNA 损伤:与人口统计学、临床和实验室参数的关系。
Int J Mol Sci. 2024 Sep 24;25(19):10293. doi: 10.3390/ijms251910293.

本文引用的文献

1
The Effects of Different Doses of ROCK Inhibitor, Antifreeze Protein III, and Boron Added to Semen Extender on Semen Freezeability of Ankara Bucks.不同剂量 ROCK 抑制剂、抗冻蛋白 III 和添加到精液稀释液中的硼对安纳托利亚公鹿精液冷冻能力的影响。
Molecules. 2022 Nov 21;27(22):8070. doi: 10.3390/molecules27228070.
2
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.描绘严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱导的宿主免疫系统与DNA损伤反应网络之间的相互作用
Vaccines (Basel). 2022 Oct 20;10(10):1764. doi: 10.3390/vaccines10101764.
3
Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against?
COVID-19患者的细胞因子模式:哪些细胞因子可预测死亡率,哪些可起到保护作用?
Curr Issues Mol Biol. 2022 Oct 10;44(10):4735-4747. doi: 10.3390/cimb44100323.
4
Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue.新型冠状病毒感染的急性后遗症:一个被忽视的公共卫生问题。
Front Public Health. 2022 Jun 17;10:908757. doi: 10.3389/fpubh.2022.908757. eCollection 2022.
5
Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.挺过风暴:SARS-CoV-2严重程度预测中的细胞因子生物标志物
Vaccines (Basel). 2022 Apr 14;10(4):614. doi: 10.3390/vaccines10040614.
6
Evaluation of 3-month follow-up of patients with postacute COVID-19 syndrome.急性新冠病毒感染后综合征患者 3 个月随访评估。
J Med Virol. 2022 May;94(5):2026-2034. doi: 10.1002/jmv.27579. Epub 2022 Jan 18.
7
Neutrophils and Lymphocytes Can Help Distinguish Asymptomatic COVID-19 From Moderate COVID-19.中性粒细胞和淋巴细胞有助于区分无症状 COVID-19 和轻症 COVID-19。
Front Cell Infect Microbiol. 2021 Oct 15;11:654272. doi: 10.3389/fcimb.2021.654272. eCollection 2021.
8
Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care.解决 SARS-CoV-2 感染的后期后遗症:一种多学科的护理模式。
Lancet Respir Med. 2021 Nov;9(11):1328-1341. doi: 10.1016/S2213-2600(21)00385-4. Epub 2021 Oct 19.
9
Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?新型冠状病毒(SARS-CoV-2)刺突蛋白的突变会导致新冠疫苗失效吗?
J Korean Med Sci. 2021 May 10;36(18):e124. doi: 10.3346/jkms.2021.36.e124.
10
Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2.COVID-19 患者不良结局的风险因素:对新型冠状病毒 SARS-CoV-2 不同反应的可能基础。
Life Sci. 2021 Jul 15;277:119503. doi: 10.1016/j.lfs.2021.119503. Epub 2021 Apr 15.